Home » CONCURRENT PHARMACEUTICALS CHANGES NAME TO VITAE PHARMACEUTICALS AND SECURES $34 MILLION IN FINANCING
CONCURRENT PHARMACEUTICALS CHANGES NAME TO VITAE PHARMACEUTICALS AND SECURES $34 MILLION IN FINANCING
Vitae Pharmaceuticals, formerly Concurrent Pharmaceuticals, has announced its new corporate branding to clearly mark its strategic evolution to a product-focused drug development company with a robust pipeline of novel clinical candidates. In addition, Vitae announced that it secured $34 million in equity financing to accelerate the company's product programs in cancer, dermatology and cardiovascular disease.
Yahoo News (http://biz.yahoo.com/prnews/050104/nytu060_1.html)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
23May
-
30May
-
13Jun
-
20Jun
-
21Oct